Evaluation of the Efficacy, Safety and Tolerance of Experimental Morning-only MOVIPREP® Bowel Preparation in Comparison With Split-dose With Nocturnal Pause MOVIPREP® Bowel Preparation

PHASE3CompletedINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

April 30, 2013

Study Completion Date

April 30, 2013

Conditions
Bowel Preparation Prior to Endoscopic, Radiological and Other Examinations as Well as to Surgical Procedures Which Require Empty Bowel.
Interventions
DRUG

MOVIPREP

MOVIPREP solution

Trial Locations (3)

Unknown

Almaty

Moscow

Saint Petersburg

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Norgine BV

UNKNOWN

lead

Takeda

INDUSTRY